Does science need a retraction “shame list?”

A pair of engineering researchers has analyzed the work of a handful of prolific scientific fraudsters, and has concluded that science needs a “shame list” to deter future misconduct. The paper, “Analysis and Implications of Retraction Period and Coauthorship of Fraudulent Publications,” by Jong Yong Abdiel Foo and Xin Ji Alan Tan, of  Ngee Ann … Continue reading Does science need a retraction “shame list?”

Weekend reads: Who plagiarizes most? Why are women cited less often? And more

It’s been another busy week at Retraction Watch. Here’s what was happening elsewhere around the web in scientific publishing, plagiarism, and retractions:

Third retraction for Karel Bezouška, of lab break-in fame

We’ve found a third retraction for Karel Bezouška, the Czech scientist, who, as we reported this summer, broke into a lab in an attempt to tamper with experiments trying to replicate his own falsified data. The article, “Molecular Characterization of Binding of Calcium and Carbohydrates by an Early Activation Antigen of Lymphocytes CD69,” had appeared … Continue reading Third retraction for Karel Bezouška, of lab break-in fame

Journal takes different tacks on two cancer papers with image problems

Carcinogenesis has the publishing world’s version of a twin problem: two dysfunctional articles yet one gets retracted while the other merely suffers a correction. Is it nature — or nurture? Here are the details. One article, “Chemopreventive effect of dietary glutamine on colitis-associated colon tumorigenesis in mice,” came from a group in China. Published earlier … Continue reading Journal takes different tacks on two cancer papers with image problems

Herbicide-ovarian cancer study to be retracted

The authors of a 2008 study purporting to explain how the herbicide atrazine acts on cancer cells have asked the journal that published it to retract it for “inadvertent errors,” Retraction Watch has learned. The notice for “G-Protein-Coupled Receptor 30 and Estrogen Receptor-a are Involved in the Proliferative Effects Induced by Atrazine in Ovarian Cancer … Continue reading Herbicide-ovarian cancer study to be retracted

France tries husband-wife team for research misconduct in plagiarism case

We’re always glad to have guest posts, and here’s one from François-Xavier Coudert, reporting from France. As we reported the other day, a Nature editorial suggested that police involvement might be an appropriate response to research misconduct. The French seem to agree, based on reports in the media there, as Coudert writes: A husband-wife team … Continue reading France tries husband-wife team for research misconduct in plagiarism case

Weekend reads: Stapel as an object lesson, peer review’s flaws, and salami slicing

It’s been another busy week at Retraction Watch. Here’s a sampling of scientific publishing and misconduct news from around the web:

“Why Growing Retractions Are (Mostly) a Good Sign”: New study makes the case

Retraction Watch readers will no doubt be familiar with the fact that retraction rates are rising, but one of the unanswered questions has been whether that increase is due to more misconduct, greater awareness, or some combination of the two. In a new paper in PLOS Medicine, Daniele Fanelli, who has studied misconduct and related … Continue reading “Why Growing Retractions Are (Mostly) a Good Sign”: New study makes the case

Melendez notches retraction 14, Lemus now stands at 12

Two researchers who have appeared frequently on Retraction Watch have racked up another retraction each. This is the fourteenth retraction for Alirio Melendez, who was found guilty of misconduct by the National University of Singapore but denies the allegations. Here’s the notice in The International Journal of Biochemistry & Cell Biology for “Environmental toxicogenomics: A … Continue reading Melendez notches retraction 14, Lemus now stands at 12

Weekend reads: China’s scientific publishing black market, how to blow the whistle, and more

It’s been a busy week here at Retraction Watch, with breaking news about hotly debated papers from Nature and about GMOs, but there have been interesting stories about retractions and scientific misconduct elsewhere, too. Here’s a sampling: